New incident report
Incident Report Number: 2009-2544
Registrant Reference Number: Prosar 1-18819858
Registrant Name (Full Legal Name no abbreviations): Syngenta Crop Protection Canada, Inc.
Address: 140 Research Lane, Research Park
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G4Z3
Human
Country: UNITED STATES
Prov / State: ALABAMA
PMRA Registration No. PMRA Submission No. EPA Registration No. 100-1091
Product Name: Reward Landscape And Aquatic Herbicide
Liquid
Yes
Unknown
Site: Pub. Area - Outdoor/Zone publique - ext
Unknown
Other
Sex: Female
Age: >64 yrs / > 64 ans
System
Unknown / Inconnu
Yes
Yes
1
Day(s) / Jour(s)
Occupational
Contact with treated area
What was the activity? weeding the treated pond
Unknown
Skin
Eye
>2 hrs <=8 hrs / >2 h <=8 h
>30 min <=2 hrs / >30 min <=2 h
1-18819858: A reporter (poison control operator) called on 06/13/2009 to report the exposure of a female to an herbicide containing the active ingredient Diquat. According to the reporter, the female patient had been weeding in a treated pond on 06/06 and developed a number of signs (described in communication with patient) after dermal and ocular exposure. The patient was seen at the emergency room the night of the exposure and has further follow up medical appointments scheduled. On follow up with the patient, complete details regarding the exposure, symptoms, and treatment were obtained. On 06/06, the patient was weeding a public pond that had been treated with the product on an unknown date. The patient was working in the treated area for 2.5 hours and was wearing non-specific gloves and a hat. She may have had abrasions near her elbow. The treated water splashed all over the front of the patient and she rubbed her eye with a water contaminated hand. After weeding the pond, she developed arm swelling and burning, itchiness, and a swollen eye. She showered and used an ice pack on her eyes. About 14 hours after product exposure, she woke up with difficulty breathing, dizziness, hives, and eyes swollen shut. She was taken to the emergency room and treated with IV medication, Benadryl injections, and a respiratory treatment. She was discharged with Medrol and antihistamines. The patient also felt that her urine was a higher temperature than her body temperature for 48 hours. She had to be seen again at the emergency room on 06/06 for worsening hives and hives in her eyes. She was treated and released. On 06/08, the caller was seen at her regular doctor as she did not feel well. Her antihistamines were changed to Zyrtec and she returned to work on 06/09. On 06/09, she was ataxic. She saw her doctor again on 06/11 and had finished the Medrol. Her doctor prescribed a course of tapering prednisone. On 06/12 through 06/16 or 06/17, she could not sleep as her eyelids would not shut. She was prescribed Ambien on 06/15. On 06/16, the patient went to work and was ataxic, weak, and her mouth felt like it was filled with cotton. She passed out and was taken to the hospital by ambulance. She was kept overnight and cardiac tests were performed. At the time of the follow up with the patient on 06/19, she was nauseous, had diarrhea, burning eyes (itchy, red, irritated, swollen) and felt like her lungs were the size of an apple. The patient had an appointment to see an allergist and an ophthalmologist. She was intending to schedule an appointment with the pulmonologist. The patient was advised that properly diluted product is unlikely to cause skin irritation. The main concern is ingestion of the concentrated product. The patient was advised that 2 weeks post exposure is too late to test for Diquat levels. A recommendation was made to continue to work with her doctors and to have them call should they need product information or a consult with a medical toxicologist. On follow up on 06/26/2009, the patient stated that she had stopped urinating for 36 hours on 06/21. She saw a doctor on 06/22 who diagnosed a urinary tract infection and a swollen kidney and started the patient on antibiotics. On an unknown date, the patient was diagnosed by an ophthalmologist with a chemical burn and a "blown out cornea". No treatment information was provided. The patient also reported that her previous signs are persistent, she has a raw throat and anxiety. She is currently on work restriction.The reporter also stated that no blood work or x-rays had been performed. On follow up on 07/14, the patient reported that she is feeling much better. She had seen an ophthalmologist on an unknown date and is being treated with Pataday eye drops for allergic conjunctivitis. Her remaining signs include the sore, swollen kidney and a large hive on her knee cap where she had had a meniscal injection 6 weeks prior to the product exposure. She saw an allergist and pulmonary
Major
doctor on an unknown date. Unspecified blood work and urine test results are expected back on 07/27. A follow up is planned to determine the results of the lab work. Exposure to a properly diluted Diquat product would not be expected to result in the extent of signs described.